A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
NCT07222488
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Bladder Cancer
Urinary Bladder Neoplasms
Interventions
BIOLOGICAL:
MK-3120
Sponsor
Merck Sharp & Dohme LLC